1. Home
  2. BDSX vs PGP Comparison

BDSX vs PGP Comparison

Compare BDSX & PGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$14.29

Market Cap

122.0M

Sector

Health Care

ML Signal

HOLD

Logo Pimco Global StocksPlus & Income Fund of Beneficial Interest

PGP

Pimco Global StocksPlus & Income Fund of Beneficial Interest

HOLD

Current Price

$8.09

Market Cap

102.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDSX
PGP
Founded
2005
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
122.0M
102.9M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
BDSX
PGP
Price
$14.29
$8.09
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$32.50
N/A
AVG Volume (30 Days)
129.7K
46.8K
Earning Date
05-12-2026
01-01-0001
Dividend Yield
N/A
10.84%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$88,499,000.00
N/A
Revenue This Year
$25.26
N/A
Revenue Next Year
$19.70
N/A
P/E Ratio
N/A
N/A
Revenue Growth
24.08
N/A
52 Week Low
$0.25
$6.56
52 Week High
$20.21
$9.41

Technical Indicators

Market Signals
Indicator
BDSX
PGP
Relative Strength Index (RSI) 44.63 25.64
Support Level $6.33 $8.04
Resistance Level $20.21 $8.15
Average True Range (ATR) 1.47 0.21
MACD -0.59 -0.04
Stochastic Oscillator 8.80 2.15

Price Performance

Historical Comparison
BDSX
PGP

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About PGP Pimco Global StocksPlus & Income Fund of Beneficial Interest

PIMCO Global Stocksplus & Income Fund is a closed-end management investment company. The objective of the fund is to seek a total return comprised of current income, current gains, and long-term capital appreciation. The fund invests a majority of the fund's net assets in a combination of securities and instruments that provide exposure to stocks and or produce income.

Share on Social Networks: